- Companies
- Drug Farm
Drug Farm Funding, Investors & Competitors
Drug Farm has raised $138M across 3 funding rounds, most recently a $55M Series D in July 2026.
Last Drug Farm funding round
$55M
Series D · Jul 2026
Cumulative funding Drug Farm raised
$138M
across 3 funding rounds
Key investors in Drug Farm
DT Capital Partners
BVCF
Wedo Venture Partners
Betta Capital
YD Capital
Wuxi AppTec
South China Venture Capital
Bull Capital
About Drug Farm
Drug Farm is a U.S.- and China-based biotechnology company engineering gene therapies for HBV, liver cancer, and autoimmune disorders via its IDInVivo platform integrating CRISPR screens and AI-driven target discovery. Headquartered in San Francisco with R&D in Shanghai, it raised $20 million in Series A funding in 2022 from Arch Venture Partners. Drug Farm's DF-001 targets HBV cccDNA clearance, entering IND-enabling studies, while DF-002 addresses PD-1 resistant tumors. The firm collaborates with WuXi AppTec for manufacturing.
Founded
2015
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Licensing, Subscription
Drug Farm Funding History
Drug Farm has raised a total of $138M across 3 funding rounds.
Drug Farm's first fundraising round was a $56M Series A in February 2021. The most recent completed round was a $55M Series D in July 2026.
Drug Farm funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Jul 2026 | Series D | Caolu Investment (lead); Chuanghe (Shanghai) Private Equity Investment Fund (lead); Shenzhen Guoxin Yihe Emerging Industry Private Equity; BVCF; Bull Capital; DT Capital Partners; Betta Capital; YD Capital; Huzhou Talent Innovation Equity Investment Fund Partnership; Wedo Venture Partners; Keyuan Pharmaceutical; Yishan Jiabao Investment | $55M | - |
| May 2023 | Series C | YD Capital (lead); DT Capital Partners; Betta Capital; Jiashan County State-owned Assets Investment; Wedo Venture Partners | $27M | Drug Farm, a biopharma company, raised $27 million in a financing round around May 16, 2023, led by YD Capital, with participation from new investors including Jiashan County State-owned Assets Investment, Betta Capital, and existing investors such as DT Capital Partners and Wedo Venture Partners. Drug Farm has announced developments like FDA acceptance of its candidate DF-003 into a rare disease program, indicating focus on drug development in areas such as rare diseases. |
| Feb 2021 | Series A | Wuxi AppTec; South China Venture Capital; BVCF; DT Capital Partners; Zuig Investment | $56M | - |
Who has invested in Drug Farm?
16 investors have backed Drug Farm across its funding rounds, including DT Capital Partners, BVCF, Wedo Venture Partners, Betta Capital, YD Capital and Wuxi AppTec.
Lead investors include Caolu Investment, Chuanghe (Shanghai) Private Equity Investment Fund and YD Capital.
Drug Farm Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 3 | Participant | Feb 2021 | ||
| 2 | Participant | Feb 2021 | ||
| -- | 2 | Participant | May 2023 | |
| 2 | Lead | May 2023 | ||
| 2 | Participant | May 2023 | ||
| 1 | Participant | Jul 2026 | ||
| 1 | Participant | Feb 2021 | ||
| 1 | Participant | Feb 2021 | ||
| 1 | Lead | Jul 2026 | ||
| 1 | Participant | Jul 2026 | ||
| 1 | Participant | Feb 2021 | ||
| 1 | Lead | Jul 2026 | ||
| 1 | Participant | May 2023 | ||
This data is available for Pro users. Sign up to see all 16 Drug Farm investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialInvestments by Drug Farm
Drug Farm has invested in 1 company to date.
Latest investment by Drug Farm was on August 23rd 2021. Drug Farm invested in NeuroDawn Pharmaceutical in their $11M Series A round.
Latest Investments by Drug Farm
| Description | NeuroDawn Pharmaceutical is a biopharmaceutical firm that designs novel therapeutics for central nervous system diseases. Its pipeline targets neurological conditions through small molecule inhibitors and modulators that address underlying disease mechanisms. Based in China, the company conducts research in Shanghai and collaborates with local institutions for preclinical and clinical development stages. |
| HQ Country | |
| HQ City | Nanjing |
| Deal Date | 23 Aug 2021 |
| Round | Series A |
| Raised | $11M |
| Investors | Dynamic Balance Capital; Simcere Pharmaceutical Group |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Drug Farm investments and their VC round multiples. Start Free Trial | |
Drug Farm Competitors
Drug Farm competitors include listed companies like SAP and Snowflake, and private ones like Astromech, Chai Discovery, Anthropic and OpenAI.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $3.8B | - | ||
| Private | $48M | - | $3.8B | - | ||
| Private | $47B | - | $965B | 20.5x | ||
| Private | $25B | - | $852B | 34.1x | ||
| Publicly listed | $42B | $13B | $248B | 5.4x | ||
| Publicly listed | $4.7B | ($1.3B) | $119B | 21.0x |
Drug Farm Public Comps
Drug Farm is still privately-owned, but its public comps include Eli Lilly, Johnson & Johnson, AbbVie, Merck, Roche, Novartis, AstraZeneca, CrowdStrike, SAP and Amgen.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $65B | $28B | 16.5x | 13.1x | 38.7x | 27.0x | |||
| $94B | $40B | 7.2x | 6.8x | 17.0x | 18.3x | |||
| $61B | $17B | 8.7x | 8.1x | 30.6x | 17.6x | |||
| $65B | $28B | 6.3x | 6.2x | 14.7x | 21.0x | |||
| $77B | $26B | 5.0x | 4.9x | 14.6x | 12.4x | |||
| $57B | $22B | 5.5x | 5.5x | 14.2x | 13.3x | |||
| $59B | $19B | 4.8x | 4.5x | 14.6x | 12.7x | |||
| $4.8B | ($12M) | 51.4x | 44.5x | (19816.2x) | 151.0x | |||
This data is available for Pro users. Sign up to see all Drug Farm competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Drug Farm
| When was Drug Farm founded? | Drug Farm was founded in 2015. |
| Where is Drug Farm headquartered? | Drug Farm is headquartered in Shanghai, China. |
| Is Drug Farm publicly listed? | No, Drug Farm is a private, VC-backed company. |
| How much funding has Drug Farm raised? | Drug Farm has raised $138M across 3 funding rounds. |
| What was Drug Farm's last funding round? | Drug Farm's last funding round was a $55M Series D in July 2026, led by Caolu Investment and Chuanghe (Shanghai) Private Equity Investment Fund. |
| Who are Drug Farm's investors? | Drug Farm's investors include DT Capital Partners, BVCF, Betta Capital, YD Capital, Wedo Venture Partners, Shenzhen Guoxin Yihe Emerging Industry Private Equity, Wuxi AppTec, South China Venture Capital, Caolu Investment, Bull Capital and 6 others. |
| Which companies are comparable to Drug Farm? | Companies comparable to Drug Farm include Astromech, Chai Discovery, Anthropic, OpenAI, SAP and Snowflake. |
| How many companies has Drug Farm invested in? | Drug Farm has invested in 1 company, including NeuroDawn Pharmaceutical. |
| What was Drug Farm's last investment? | In August 2021, Drug Farm invested in NeuroDawn Pharmaceutical's $11M Series A alongside Dynamic Balance Capital and Simcere Pharmaceutical Group. |
See companies similar to Drug Farm
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




